Literature DB >> 23748398

Abortion services in a high-needs district: a community-based model of care.

Simon Snook1, Martha Silva.   

Abstract

INTRODUCTION: In 2009, a high-deprivation district health board in New Zealand set up a community-based abortion clinic in order to provide a local service and to avoid out-of-region referrals. The service offers medical abortions for women with pregnancies of up to 63 days' gestation, and surgical abortion with local anaesthetic for women with pregnancies of up to 14 weeks' gestation. AIM: To describe the services developed and assess safety and timeliness for the first year of community-based services.
METHODS: An audit of clinical records for patients seen in 2010 was performed in order to obtain data on location of services, timeliness, safety and complications.
RESULTS: Eighty-two percent of locally provided abortions in 2010 were medical abortions, completed on average less than two days after referral to the service. One percent of patients experienced haemorrhaging post abortion, and 4% had retained products. These rates are within accepted standards for an abortion service. DISCUSSION: This report illustrates that a community-based model of care can be both clinically and culturally safe, while providing a much-needed service to a high-needs population.

Entities:  

Mesh:

Year:  2013        PMID: 23748398

Source DB:  PubMed          Journal:  J Prim Health Care        ISSN: 1172-6156


  2 in total

Review 1.  Towards comprehensive early abortion service delivery in high income countries: insights for improving universal access to abortion in Australia.

Authors:  Angela Dawson; Deborah Bateson; Jane Estoesta; Elizabeth Sullivan
Journal:  BMC Health Serv Res       Date:  2016-10-22       Impact factor: 2.655

2.  Medical termination of pregnancy in general practice in Australia: a descriptive-interpretive qualitative study.

Authors:  Angela J Dawson; Rachel Nicolls; Deborah Bateson; Anna Doab; Jane Estoesta; Ann Brassil; Elizabeth A Sullivan
Journal:  Reprod Health       Date:  2017-03-14       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.